LRB 057

Drug Profile

LRB 057

Latest Information Update: 16 Jan 1996

Price : $50

At a glance

  • Originator Istituto Lusofarmaco
  • Class Antihypertensives
  • Mechanism of Action Angiotensin receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Heart failure; Hypertension

Most Recent Events

  • 16 Jan 1996 Discontinued-Preclinical for Heart failure in Italy (Unknown route)
  • 16 Jan 1996 Discontinued-Preclinical for Hypertension in Italy (PO)
  • 04 Apr 1995 An in vitro and in vivo study has been added to the Hypertension pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top